RHHBF
Price
$308.08
Change
+$22.32 (+7.81%)
Updated
Dec 16 closing price
RHHBY
Price
$35.84
Change
+$0.30 (+0.84%)
Updated
Dec 17 closing price
43 days until earnings call
Ad is loading...

RHHBF vs RHHBY

Header iconRHHBF vs RHHBY Comparison
Open Charts RHHBF vs RHHBYBanner chart's image
Roche Holding
Price$308.08
Change+$22.32 (+7.81%)
Volume$56
CapitalizationN/A
Roche Holding
Price$35.84
Change+$0.30 (+0.84%)
Volume$2.03M
CapitalizationN/A
RHHBF vs RHHBY Comparison Chart
Loading...
RHHBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RHHBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RHHBF vs. RHHBY commentary
Dec 18, 2024

To understand the difference between Roche Holding AG - Bearer Shares (RHHBF) vs. Roche Holding AG - ADR (RHHBY) it is enough to know the definitions of Bearer Shares and ADR

Bearer Shares - Bearer shares are unregistered equity securities owned by the possessor of the physical share documents. The issuing firm neither registers the owner of the stock nor tracks transfers of ownership. Dividends are paid to owners of the physical coupons.

ADR - American depositary receipt (ADR) is a certificate issued by a U.S. depositary bank representing a specified number of shares (often 1 share) of a foreign company's stock. ADRs are denominated in U.S. dollars and trade on U.S. stock markets and OTC depending on the ADRs classification.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (RHHBF: $308.08 vs. RHHBY: $35.84)
Brand notoriety: RHHBF and RHHBY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: RHHBF: 59% vs. RHHBY: 179%
Market capitalization -- RHHBF: $250.69B vs. RHHBY: $250.69B
RHHBF [@Pharmaceuticals: Major] is valued at $250.69B. RHHBY’s [@Pharmaceuticals: Major] market capitalization is $250.69B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RHHBF’s FA Score shows that 2 FA rating(s) are green whileRHHBY’s FA Score has 1 green FA rating(s).

  • RHHBF’s FA Score: 2 green, 3 red.
  • RHHBY’s FA Score: 1 green, 4 red.
According to our system of comparison, both RHHBF and RHHBY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RHHBF’s TA Score shows that 5 TA indicator(s) are bullish while RHHBY’s TA Score has 4 bullish TA indicator(s).

  • RHHBF’s TA Score: 5 bullish, 5 bearish.
  • RHHBY’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, RHHBY is a better buy in the short-term than RHHBF.

Price Growth

RHHBF (@Pharmaceuticals: Major) experienced а -2.52% price change this week, while RHHBY (@Pharmaceuticals: Major) price change was +0.56% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.90%. For the same industry, the average monthly price growth was -3.44%, and the average quarterly price growth was -1.16%.

Reported Earning Dates

RHHBY is expected to report earnings on Jan 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.90% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RHHBF($251B) and RHHBY($251B) have the same market capitalization . RHHBF has higher P/E ratio than RHHBY: RHHBF (21.19) vs RHHBY (19.46). RHHBY YTD gains are higher at: 2.985 vs. RHHBF (-0.937). RHHBF (19.1B) and RHHBY (19.1B) have comparable annual earnings (EBITDA) . RHHBF (7.51B) and RHHBY (7.51B) have equal amount of cash in the bank . RHHBF (25.4B) and RHHBY (25.4B) have identical debt. RHHBF (60B) and RHHBY (60B) have equivalent revenues.
RHHBFRHHBYRHHBF / RHHBY
Capitalization251B251B100%
EBITDA19.1B19.1B100%
Gain YTD-0.9372.985-31%
P/E Ratio21.1919.46109%
Revenue60B60B100%
Total Cash7.51B7.51B100%
Total Debt25.4B25.4B100%
FUNDAMENTALS RATINGS
RHHBF vs RHHBY: Fundamental Ratings
RHHBF
RHHBY
OUTLOOK RATING
1..100
5163
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
12
Undervalued
PROFIT vs RISK RATING
1..100
9679
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
5758
P/E GROWTH RATING
1..100
2937
SEASONALITY SCORE
1..100
n/a42

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RHHBY's Valuation (12) in the null industry is in the same range as RHHBF (15). This means that RHHBY’s stock grew similarly to RHHBF’s over the last 12 months.

RHHBY's Profit vs Risk Rating (79) in the null industry is in the same range as RHHBF (96). This means that RHHBY’s stock grew similarly to RHHBF’s over the last 12 months.

RHHBY's SMR Rating (98) in the null industry is in the same range as RHHBF (98). This means that RHHBY’s stock grew similarly to RHHBF’s over the last 12 months.

RHHBF's Price Growth Rating (57) in the null industry is in the same range as RHHBY (58). This means that RHHBF’s stock grew similarly to RHHBY’s over the last 12 months.

RHHBF's P/E Growth Rating (29) in the null industry is in the same range as RHHBY (37). This means that RHHBF’s stock grew similarly to RHHBY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RHHBFRHHBY
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
60%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
60%
Momentum
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
47%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
59%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
54%
Bullish Trend 2 days ago
49%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
50%
Advances
ODDS (%)
Bullish Trend 23 days ago
59%
Bullish Trend 2 days ago
51%
Declines
ODDS (%)
Bearish Trend 6 days ago
50%
Bearish Trend 6 days ago
45%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
69%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
45%
View a ticker or compare two or three
Ad is loading...
RHHBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RHHBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TYLG34.61N/A
N/A
Global X Information Tch Cvd Cll&Gr ETF
PSCH46.35-0.26
-0.56%
Invesco S&P SmallCap Health Care ETF
AVLV68.28-0.55
-0.79%
Avantis US Large Cap Value ETF
ICAP27.12-0.25
-0.92%
InfraCap Equity Income ETF
FSMD42.90-0.41
-0.95%
Fidelity Small-Mid Multifactor ETF

RHHBF and

Correlation & Price change

A.I.dvisor tells us that RHHBF and RHHBY have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RHHBF and RHHBY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHBF
1D Price
Change %
RHHBF100%
N/A
RHHBY - RHHBF
32%
Poorly correlated
+0.84%
RHHVF - RHHBF
25%
Poorly correlated
+1.90%
NVS - RHHBF
20%
Poorly correlated
+1.36%
JNJ - RHHBF
16%
Poorly correlated
+1.78%
ABBV - RHHBF
16%
Poorly correlated
+2.18%
More

RHHBY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RHHBY has been loosely correlated with RHHVF. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if RHHBY jumps, then RHHVF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHBY
1D Price
Change %
RHHBY100%
+0.84%
RHHVF - RHHBY
65%
Loosely correlated
+1.90%
NVS - RHHBY
37%
Loosely correlated
+1.36%
JNJ - RHHBY
37%
Loosely correlated
+1.78%
RHHBF - RHHBY
32%
Poorly correlated
N/A
BMY - RHHBY
28%
Poorly correlated
+3.19%
More